Meyahealth
HomeGeneticsConditionGRN-related frontotemporal lobar degeneration
Back to Condition
GRN-related frontotemporal lobar degeneration
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Condition

GRN-related frontotemporal lobar degeneration

GRN-related frontotemporal lobar degeneration is a progressive brain disorder that impacts behavior, language, and movement, typically manifesting in mid-to-late adulthood.

Overview

GRN-related frontotemporal lobar degeneration is a progressive brain disorder that can affect behavior, language, and movement. Symptoms usually become noticeable in a person's fifties or sixties, though they can begin as early as the thirties or as late as the eighties. Affected people typically survive 7 to 13 years after the appearance of symptoms.

Symptoms

Behavioral and Cognitive Changes

  • Marked changes in personality, judgment, and insight
  • Difficulty interacting in a socially appropriate manner
  • Distractibility and inability to complete tasks
  • Decline in intellectual function (dementia)

Speech and Language

  • Progressive problems with speech and language (aphasia)
  • Trouble speaking, remembering words and names (dysnomia), and understanding speech
  • Potential loss of the ability to communicate (mutism)

Movement Disorders

  • Tremors
  • Muscle stiffness (rigidity)
  • Unusually slow movement (bradykinesia)
  • Walking problems (gait disturbance)
  • Involuntary muscle spasms (myoclonus)
  • Uncontrolled muscle tensing (dystonia)
  • Inability to carry out purposeful movements (apraxia)

Causes

This disorder results from mutations in the GRN gene, which provides instructions for making a protein called progranulin. Progranulin is active in many tissues and appears to play an important role in the survival of nerve cells. Most mutations prevent the production of progranulin from one copy of the gene, resulting in a shortage of the protein.

The disorder is characterized by the buildup of a protein called TAR DNA-binding protein 43 (TDP-43) in certain brain cells. These clumps may interfere with cell functions and lead to cell death. The features of the condition result from the gradual loss of neurons in the frontal and temporal lobes of the brain.

Inheritance

GRN-related frontotemporal lobar degeneration has a pattern of inheritance known as incomplete autosomal dominance. Having one copy of the altered gene generally results in milder signs and symptoms than having both copies. In most cases, an affected person has a parent and other family members with the condition.

Frequently Asked Questions

Diagnosis combines clinical assessment, neuropsychological testing, and imaging (MRI or PET scans) to detect characteristic brain atrophy. Genetic testing for GRN mutations is performed via a blood sample; the test looks for deletions, insertions, or point mutations. Results are interpreted by a geneticist, and a positive finding confirms the diagnosis and informs family risk.
Most patients live 7 to 13 years after symptom onset, but this varies. Early involvement of multidisciplinary teams—neurologists, psychiatrists, occupational therapists, and social workers—can improve quality of life. Support groups, caregiver education programs, and respite care services are available through national FTD foundations and local hospitals.
Early signs often include subtle personality shifts such as increased irritability, socially inappropriate remarks, or a noticeable loss of empathy. You might also notice difficulty following conversations, forgetting familiar names, or a decline in routine organization. If these changes persist for more than a few weeks, a neurologist should evaluate you.
Speech‑language therapy focuses on maintaining communication strategies, using alternative communication devices, and practicing naming exercises. Pharmacologic options like cholinesterase inhibitors may offer modest benefits. Regular therapy sessions (2–3 times per week) can slow decline, and caregivers should be trained in supportive communication techniques.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA

About UsTerms & PolicyFAQ